Preproorexin and Orexin Receptors Are Expressed in Cortisol-Secreting Adrenocortical Adenomas, and Orexins Stimulate in Vitro Cortisol Secretion and Growth of Tumor Cells
R. Spinazzi1,
M. Rucinski1,
G. Neri,
L. K. Malendowicz and
G. G. Nussdorfer
Department of Human Anatomy and Physiology (R.S., G.N., G.G.N.), Section of Anatomy, University of Padua, I-35121 Padua, Italy; and Department of Histology and Embryology (M.R., L.K.M.), Poznan School of Medicine, PL-60781 Poznan, Poland
Address all correspondence and requests for reprints to: Professor G. G. Nussdorfer, Department of Human Anatomy and Physiology, Section of Anatomy, University of Padova, Via Gabelli 65, I-35121 Padova, Italy. E-mail: gastone.nusdorfer{at}unipd.it.
Orexins A and B are hypothalamic peptides that originate fromthe proteolytic cleavage of preproorexin and act through twosubtypes of receptors, named OX1-R and OX2-R. OX1-R almost exclusivelybinds orexin-A, whereas OX2-R is nonselective for both orexins.We previously found that orexin-A, via the OX1-R, stimulatescortisol secretion from dispersed human adrenocortical cells.In this study, we demonstrate that six of eight cortisol-secretingadenomas expressed preproorexin mRNA, and seven of 10 adenomascontained measurable amounts of orexin-A but not orexin-B. Normaladrenal cortexes neither expressed preproorexin nor containedorexins. All adenomas expressed OX1-R and OX2-R mRNAs, and real-timePCR showed that the expression of both receptors was up-regulatedin adenomas, compared with normal adrenal cortex. Orexin-A concentration-dependentlyraised basal cortisol secretion from freshly dispersed normaland adenomatous cells, minimal and maximal effective concentrationsbeing 1010 and 108 M, and the peptide efficacy(percent increase elicited by 108 M orexin-A) was significantlyhigher in adenomas than in the normal adrenal cortex. Orexin-Bwas ineffective, thereby indicating that orexin secretagogueaction is mediated by the OX1-R. In contrast, both orexins (108M) raised the proliferative activity of cultured normal andadenomatous cells, suggesting that this effect is mediated byOX2-R or both receptor subtypes. Collectively, our findingsallow us to conclude that the orexin system is overexpressedin cortisol-secreting adenomas and suggest that orexin-A mayact as an autocrine-paracrine regulator of the secretory activityand growth of some of these adrenal tumors.
This article has been cited by other articles:
J. Wenzel, N. Grabinski, C. A. Knopp, A. Dendorfer, M. Ramanjaneya, H. S. Randeva, M. Ehrhart-Bornstein, P. Dominiak, and O. Johren Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 2009;
297(5):
R1601 - R1609.
[Abstract][Full Text][PDF]
M. Ramanjaneya, A. C Conner, J. Chen, P. Kumar, J. E P Brown, O. Johren, H. Lehnert, P. R Stanfield, and H. S Randeva Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B
J. Endocrinol.,
August 1, 2009;
202(2):
249 - 261.
[Abstract][Full Text][PDF]
M. Ramanjaneya, A. C. Conner, J. Chen, P. R. Stanfield, and H. S. Randeva Orexins Stimulate Steroidogenic Acute Regulatory Protein Expression through Multiple Signaling Pathways in Human Adrenal H295R Cells
Endocrinology,
August 1, 2008;
149(8):
4106 - 4115.
[Abstract][Full Text][PDF]
M. W. Bengtsson, K. Makela, M. Sjoblom, S. Uotila, K. E. O. Akerman, K.-H. Herzig, and G. Flemstrom Food-induced expression of orexin receptors in rat duodenal mucosa regulates the bicarbonate secretory response to orexin-A
Am J Physiol Gastrointest Liver Physiol,
August 1, 2007;
293(2):
G501 - G509.
[Abstract][Full Text][PDF]
J E Digby, J Chen, J Y Tang, H Lehnert, R N Matthews, and H S Randeva Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B.
J. Endocrinol.,
October 1, 2006;
191(1):
129 - 136.
[Abstract][Full Text][PDF]
R. Spinazzi, P. G. Andreis, G. P. Rossi, and G. G. Nussdorfer Orexins in the regulation of the hypothalamic-pituitary-adrenal axis.
Pharmacol. Rev.,
March 1, 2006;
58(1):
46 - 57.
[Abstract][Full Text][PDF]